Clinical value of hemoglobin and its association with hepatocyte steatosis in chronic hepatitis B patients

Wang Peng; Zhang ZhiQiao; Lu: GuoTao; Wang GongSui; Chen XiaoQiao; Ming Lang; Zheng Chong; Chen LeWu; Xie QiuLi; He JieXiong; Huang Yong

doi:10.3969/j.issn.1001-5256.2017.07.014

Issue 7

Jul. 2017

Turn off MathJax

Article Contents

Abstract

References

Article Navigation > Journal of Clinical Hepatology > 2017 > 33(7): 1274-1279

PDF( 1731 KB)

Clinical value of hemoglobin and its association with hepatocyte steatosis in chronic hepatitis B patients

DOI: 10.3969/j.issn.1001-5256.2017.07.014

Department of Infectious Diseases, The First People's Hospital of Shunde

Research funding:

Received Date: 2017-01-13
Published Date: 2017-07-20

Abstract

Abstract

Objective To investigate the clinical value of hemoglobin and its association with hepatocyte steatosis in chronic hepatitis B (CHB) patients.Methods A retrospective analysis was performed for the clinical and pathological data of 1580 CHB patients who were hospitalized in The First People's Hospital of Shunde from January 2006 to December 2014 and underwent liver biopsy, among whom 216 (13.67%) had hepatocyte steatosis (hepatocyte steatosis group) and 1364 had no hepatocyte steatosis (non-hepatocyte steatosis group) .The patients were divided into groups 1, 2, and 3 according to hemoglobin level, and the clinical and pathological features were analyzed and compared between the three groups.The t-test was used for comparison of continuous data between group;a one-way analysis of variance was used for comparision between multiple groups.The Mann-Whitney U test was used for ranked data between groups.The Kruskal-wallis H test was used for ranked data between multiple groups;the chi-square test was used for comparison of categorical data between groups.Spearman correlation analysis was also performed to determine the correlation between two variables.Univariate logistic regression analysis and multivariate stepwise regression analysis were used to identify the influencing factors for hepatocyte steatosis.Results Body mass index (BMI) , systolic pressure, diastolic pressure, uric acid, total cholesterol, low-density lipoprotein, and HBV DNA load increased with the increase in hemoglobin level (F=12.718, 3.024, 4.026, 4.624, 38.276, 28.108, 7.358, all P<0.05) .The incidence rates of hepatocyte steatosis in groups 1, 2, and 3 were 7.59%, 11.76%, and 21.67%, respectively (χ2=44.23, P<0.05) .Hemoglobin was positively correlated with hepatic steatosis (rs=0.211, P<0.001) .The multivariate logistic regression analysis showed that hemoglobin (odds ratio [OR]=1.066, P<0.05) , BMI (OR=1.576, P<0.05) , age (OR=1.041, P<0.05) , sex (OR=0.261, P<0.05) , aspartate aminotransferase (OR=0.987, P<0.05) , triglyceride (OR=1.690, P<0.05) , and uric acid (OR=1.006, P<0.05) were independent influencing factors for hepatocyte steatosis in CHB patients.The area under the receiver operating characteristic curve was 0.852 (95% confidence interval [CI]:0.811-0.893, P<0.01) for BMI, 0.701 (95% CI:0.662-0.740, P<0.01) for low-density lipoprotein, 0.694 (95% CI:0.653-0.734, P<0.01) for triglyceride, 0.689 (95% CI:0.650-0.728, P<0.01) for total cholesterol, 0.675 (95% CI:0.637-0.714, P<0.01) for hemoglobin, 0.654 (95% CI:0.617-0.691, P<0.01) for age, 0.619 (95%CI:0.575-0.662, P<0.01) for uric acid, and 0.612 (95% CI:0.569-0.655, P<0.01) for blood glucose.Conclusion CHB patients with a high hemoglobin level tend to develop hepatocyte steatosis, and hemoglobin may be an independent influencing factor for hepatocyte steatosis in CHB patients.A high hemoglobin level has a certain value in predicting hepatocyte steatosis and awaits further research.
- hepatitis B, chronic,
- hemoglobins,
- fatty liver,
- regression analysis

FullText(HTML)

References(16)

References

[1]LU FM, ZHUANG H.Management of hepatitis B in China[J].Chin Med J, 2009, 122 (1) :3-4.

[2]LI N, LI HB, ZHU L, et al.Diagnostic value of fibrinogen and routine blood tests for hepatitis B[J].Int J Virol, 2016, 23 (1) :38-40. (in Chinese) 李娜, 李宏斌, 朱蕾, 等.纤维蛋白原和血常规检测对乙型肝炎的诊断价值[J].国际病毒学杂志, 2016, 23 (1) :38-40.

[3]BELLENTANI S, SCAGLIONI F, MARINO M, et al.Epidemiology of non-alcoholic fatty liver disease[J].Dig Dis Dis, 2010, 28 (1) :155-161.

[4]MACHADO MV, OLIVEIRA AG, CORTEZ-PINTO H.Hepatic steatosis in hepatitis B virus infected patients:Meta-analysis of risk factors and comparison with hepatitis C infected patients[J].JGastroenterol Hepatol, 2011, 26 (9) :1361-1367.

[5]SUNG KC, RYAN MC, WILSON AM.The severity of nonalcoholic fatty liver disease is associated with increased cardiovascular risk in a large cohort of non-obese Asian subjects[J].Atherosclerosis, 2009, 203 (2) :581-586.

[6]JIN X, CHEN YP, YANG YD, et al.Association between hepatic steatosis and entecavir treatment failure in Chinese patients with chronic hepatitis B[J].PLo S One, 2012, 7 (3) :e34198.

[7]TRAK-SMAYRA V, DARGERE D, NOUN R, et al.Serum proteomic profiling of obese patients:correlation with liver pathology and evolution after bariatric surgery[J].Gut, 2009, 58 (6) :825-832.

[8]XU L, XU CF, YU CH, et al.Haemoglobin and non-alcoholic fatty liver disease:further evidence from a population-based study[J].Gut, 2009, 58 (12) :1706-1707.

[9]YU C, XU C, XU L, et al.Serum proteomic analysis revealed diagnostic value of hemoglobin for nonalcoholic fatty liver disease[J].J Hepatol, 2012, 56 (1) :241-247.

[10]Chinese Society of Hepatology, Chinese Society of Infectious Diseases, Chinese Medical Association.The guideline of prevention and treatment for chronic hepatitis B (2010 version) [J].J Clin Hepatol, 2011, 27 (1) :Ⅰ-ⅩⅥ. (in Chinese) 中华医学会肝病学分会, 中华医学会感染病学分会.慢性乙型肝炎防治指南 (2010版) [J].临床肝胆病杂志, 2011, 27 (1) :Ⅰ-ⅩⅥ.

[11]KLEINER DE, BRUNT EM.Nonalcoholic fatty liver disease:pathologic patterns and biopsy evaluation in clinical research[J].Semin Liver Dis, 2012, 32 (1) :3-13.

[12]YILMAZ Y, SENATES E, AYYILDIZ T, et al.Characterization of nonalcoholic fatty liver disease unrelated to the metabolic syndrome[J].Eur J Clin Invest, 2011, 42 (4) :411-418.

[13]CAI W, ZHANG B, MIAO L, et al.Prospective cohort study of the predictive value of hemoglobin levels for non-alcoholic fatty liver disease[J].Chin J Hepatol, 2014, 22 (3) :200-204. (in Chinese) 蔡雯, 张蓓, 苗蕾, 等.血红蛋白浓度预测非酒精性脂肪性肝病的前瞻性队列研究[J].中华肝脏病杂志, 2014, 22 (3) :200-204.

[14]SU DZ, AI LY, WANG XH, et al.Study on the risk of non-alcoholic fatty liver disease caused by high hemoglobin level:the impact of gender[J].Chin Hepatol, 2013, 18 (11) :728-732. (in Chinese) 苏大芝, 艾罗燕, 王晓晗, 等.不同性别高血红蛋白水平对非酒精性脂肪性肝病发生风险的影响[J].肝脏, 2013, 18 (11) :728-732.

[15]LIU XT, TAO LX, YANG K, et al.Association between hemoglobin and metabolic syndrome:a five-year follow-up[J].J Capit Med Univ, 2016, 37 (4) :509-512. (in Chinese) 刘相佟, 陶丽新, 杨昆, 等.血红蛋白与成人代谢综合征及其组分关联性的五年队列研究[J].首都医科大学学报, 2016, 37 (4) :509-512.

[16]ZHANG ZG, XUE L, ZHANG YX, et al.Analysis of the prevalence of nonalcoholic fatty liver disease in uygur civil servants in urumqi[J].Modern Prevent Med, 2012, 39 (8) :1955-1957. (in Chinese) 张泽高, 薛黎, 张跃新, 等.乌鲁木齐市公务员非酒精性脂肪肝调查[J].现代预防医学, 2012, 39 (8) :1955-1957.

Relative Articles

[1]	Ying LIN, Li CHEN, Fei PENG, Jianhui LIN, Chuanshang ZHUO. Changes in hemoglobin and related influencing factors in patients with liver failure undergoing artificial liver support therapy[J]. Journal of Clinical Hepatology, 2025, 41(1): 104-109. doi: 10.12449/JCH250116
[2]	Huang YingTing, Dai Biao. Association between fatty liver disease and lacunar infarction[J]. Journal of Clinical Hepatology, 2018, 34(12): 2619-2623. doi: 10.3969/j.issn.1001-5256.2018.12.022
[3]	Meng YuLin, Zhang HaiYan, Song BaoGuo, Zhou HuiLan, Jin XiuPing, Shi GuoHui. An investigation of the prevalence rate of fatty liver disease among people undergoing physical examination in Tangshan, China[J]. Journal of Clinical Hepatology, 2017, 33(12): 2376-2380. doi: 10.3969/j.issn.1001-5256.2017.12.024
[4]	Xu QingNian, Lu YunFei, Tang BoZong, Chen XiaoRong, Yang ZongGuo. Correlation between mRNA expression of heat shock protein in tumor tissue and tumor stage in patients with HBV-related hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2017, 33(5): 869-874. doi: 10.3969/j.issn.1001-5256.2017.05.015
[5]	Wang Peng, Zhang ZhiQiao, Kang KaiFu, Wu GuoBiao. Classification tree model analysis of influencing factors for hepatocyte steatosis in patients with chronic hepatitis B[J]. Journal of Clinical Hepatology, 2016, 32(3): 476-479. doi: 10.3969/j.issn.1001-5256.2016.03.015
[6]	Cui YanPing, Li QingFang, Li QingYan, Liu ChunHua, Wang WeiHong, Yuan JianGuo, Wang SiKui. Logistic regression analysis of prognostic risk factors for hepatic encephalopathy[J]. Journal of Clinical Hepatology, 2016, 32(1): 135-138. doi: 10.3969/j.issn.1001-5256.2016.01.026
[7]	Zhang ZhiQiao, Wang GongSui, Kang KaiFu, Wu GuoBiao, Wang Peng. Prevalence and clinical features of hepatic steatosis in patients with chronic hepatitis B[J]. Journal of Clinical Hepatology, 2015, 31(7): 1063-1067. doi: 10.3969/j.issn.1001-5256.2015.07.016
[8]	Zhang ZhiQiao, Wang GongSui, Kang KaiFu, Wu GuoBiao, Wang Peng. Analysis of high-risk groups and predictive factors for hepatic steatosis in patients with chronic hepatitis B[J]. Journal of Clinical Hepatology, 2015, 31(7): 1123-1125. doi: 10.3969/j.issn.1001-5256.2015.07.030
[9]	Gao Rui, Liu ZhongJing, Chen Fei, Gao Lei, Jiang ChuanWu. Multivariate regression analysis of risk factors for HBV-related primary liver cancer[J]. Journal of Clinical Hepatology, 2014, 30(4): 370-372. doi: 10.3969/j.issn.1001-5256.2014.04.021
[10]	Peng Hong, Yang Jian, Mai RunZhang, Chen HongTao. Relationship between serum adiponectin level and metabolic indices in patients with chronic hepatitis B[J]. Journal of Clinical Hepatology, 2014, 30(4): 354-356. doi: 10.3969/j.issn.1001-5256.2014.04.016
[11]	Pang XueQin, Chen WeiChang, Feng Huang, Tian WenYan. Risk factors for non- alcoholic fatty liver disease: a multivariate analysis[J]. Journal of Clinical Hepatology, 2014, 30(9): 903-905. doi: 10.3969/j.issn.1001-5256.2014.09.016
[12]	Guo RuYi, Yu XuePing, Su ZhiJun, Lin ChengZu, Lin ZhiPeng, Lin Qi. Evaluation of telbivudine’s efficacy for treating HBeAg-positive chronic B hepatitis patients and identification of its predictive factors by logistic regression analysis[J]. Journal of Clinical Hepatology, 2013, 29(2): 97-100.
[13]	Lu: RiYing, Li ShiXiong, Wu JiZhou, Zhu YuJia, Fu ShaoPing. Development of a prognostic factors model for severe hepatitis[J]. Journal of Clinical Hepatology, 2012, 28(10): 789-792.
[14]	Yin ShouYi, Liu Tao, Wei HuaFeng, Ji Guang. Syndrome differentiation of fatty liver based on the whole network analysis theory[J]. Journal of Clinical Hepatology, 2011, 27(5): 474-478.
[15]	Zou ZhiQiang, Qiang ChunQian, Li YanFang, Liu YouDe, Lang ZhenWei. The clinical features and related factors of chronic hepatitis B with hepatic steatosis[J]. Journal of Clinical Hepatology, 2011, 27(6): 620-622.
[16]	Xiang GuoQing, Meng XiaoDan, Wang BingYuan. Prevalence of fatty liver among people with different occupation in Shenyang[J]. Journal of Clinical Hepatology, 2010, 26(3): 283-285.
[17]	Qin YongJun, Sun JieSheng, Wang BingYuan, Liu PengLiang, Sun FuRong, Liu CuiXiang, Xie DaWei. The differences of the blood routine indexes in patients with fatty liver and non-fatty liver[J]. Journal of Clinical Hepatology, 2010, 26(2): 163-166.
[19]	Ding YanHua, He ShuMei, Wang XiaoWei, Xu MaoFeng, Niu JunQi. The clinical feature of 198 patients with fatty liver[J]. Journal of Clinical Hepatology, 2004, 20(5): 287-288.

Supplements(0)

Cited By

Cited by

Periodical cited type(3)

1.	武丽萍，李鸿彬，许晓东. 合并脂肪肝对慢性乙型肝炎患者抗病毒治疗后病毒学应答的影响. 肝脏. 2019(06): 655-658 .
2.	袁剑峰，张志勇. 慢性乙型肝炎病人MANF蛋白的表达及意义. 蚌埠医学院学报. 2018(09): 1166-1168+1172 .
3.	黄春明，聂玉强，胡中伟，杨湛，周永健，詹远京，郭家伟，余卫华，欧志涛. 血尿酸在慢性乙型肝炎合并非酒精性脂肪性肝病中的临床意义. 胃肠病学和肝病学杂志. 2018(10): 1125-1130 .

Other cited types(0)

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Get Citation

PDF

XML

Article Metrics

Article views (2552) PDF downloads(446)

Clinical value of hemoglobin and its association with hepatocyte steatosis in chronic hepatitis B patients

DOI: 10.3969/j.issn.1001-5256.2017.07.014